A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme

By Groves Morris   Puduvalli Vinay   Chang Susan   Conrad Charles   Gilbert Mark   Tremont-Lukats Ivo   Liu Ta-Jen   Peterson Pamela   Schiff David   Cloughesy Timothy   Wen Patrick   Greenberg Harry   Abrey Lauren   DeAngelis Lisa   Hess Kenneth   Lamborn Kathleen   Prados Michael   Yung W.  

Journal of Neuro-Oncology, Vol. 81, Iss. 3, 2007-02 ,pp. : 271-277

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of temozolomide in children with recurrent high-grade glioma

By Ruggiero A.   Cefalo G.   Garré M.L.   Massimino M.   Colosimo C.   Attinà G.   Lazzareschi I.   Maurizi P.   Ridola V.   Mazzarella G.   Caldarelli M.   Rocco C.   Madon E.   Abate M.E.   Clerico A.   Sandri A.   Riccardi R.  

Journal of Neuro-Oncology, Vol. 77, Iss. 1, 2006-03 ,pp. : 89-94

Springer Publishing Company

Access to resources Recommend Favorite

Temozolomide and 13- cis retinoic acid in patients with anaplastic gliomas: a prospective single-arm monocentric phase-II study (RNOP-05)

By Grauer Oliver  

Journal of Neuro-Oncology, Vol. 104, Iss. 3, 2011-09 ,pp. : 801-809

Springer Publishing Company

Access to resources Recommend Favorite

Temozolomide treatment for newly diagnosed anaplastic oligodendrogliomas: a clinical efficacy trial

By Taliansky-Aronov A   Bokstein F   Lavon I   Siegal T  

Journal of Neuro-Oncology, Vol. 79, Iss. 2, 2006-09 ,pp. : 153-157

Springer Publishing Company

Access to resources Recommend Favorite

Toxicity and efficacy of protracted low dose temozolomide for the treatment of low grade gliomas

By Pouratian Nader   Gasco Jaime   Sherman Jonathan   Shaffrey Mark   Schiff David  

Journal of Neuro-Oncology, Vol. 82, Iss. 3, 2007-05 ,pp. : 281-288

Springer Publishing Company

Access to resources Recommend Favorite